Editas CEO to testify at U.S. Senate hearing on gene editing potential, ethics
November 07, 2017 at 14:28 PM EST
The hearing, titled “Gene Editing Technology: Innovation and Impact,” will also feature testimony from a Stanford University scientist and a bioethicist at Johns Hopkins University.